Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

May 01, 2011 (Vol. 31, No. 9)

GEN's 30th Anniversary: Fabs

  • With a number of monoclonal antibody products already on the market and many others in clinical trials, it’s clear that mAbs play an essential role in diagnosing and treating various diseases and medical disorders in the 21st century. But smaller genetically engineered antibody fragments (e.g., Fab, scFv) are catching ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.